A novel study published in Advances in Therapy has found that AstaReal's astaxanthin can improve symptoms of chronic digital eye strain in children.
The antioxidant carotenoid also improved objective measures of visual functioning, suggesting that the nutraceutical could be a helpful intervention in children's eye health.
This follows the company recent findings on cardiovascular health in firefighters.
To find out more about the new study, the molecular mechanisms by which the ingredient functions to support eye health and the formulation potential of astaxanthin for children, Annabel Kartal-Allen caught up with Dr Behnaz Shakersain, Manager of Scientific Affairs at AstaReal.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Nutraceutical Business Review.
Subscribe now Already a subscriber? Sign in here.